Two Sigma Investments, LP Bellerophon Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.38 - $0.76 $3,847 - $7,694	10,124 Added 9.75%	113,911 $45,000
Q2 2023 Aug 14, 2023	BUY	$0.68 - $12.39 $70,575 - $1.29 Million	103,787 New	103,787 $71,000
Q1 2021 May 17, 2021	SELL	$5.07 - $8.27 $99,853 - $162,877	-19,695 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.12 - $10.37 $55,220 - $93,568	-9,023 Reduced 31.42%	19,695 $131,000
Q3 2020 Nov 16, 2020	BUY	$9.27 - $13.79 $266,215 - $396,021	28,718 New	28,718 $292,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $382K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.